{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T05:14:58Z","timestamp":1721106898915},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s00105-023-05143-4","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T10:02:41Z","timestamp":1684922561000},"page":"425-429","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Neue Leitlinie und neue Therapiem\u00f6glichkeiten beim Handekzem","New guideline and treatment options for hand eczema"],"prefix":"10.1007","volume":"74","author":[{"given":"Andrea","family":"Bauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margitta","family":"Worm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,24]]},"reference":[{"key":"5143_CR1","doi-asserted-by":"crossref","unstructured":"Bauer A, Brans R, Brehler R, B\u00fcttner M, Dickel H, Elsner P, Fartasch M, John SM, K\u00f6llner A, Maul JT, Merk H, Molin S, Nikolakis G, Schliemann S, Simon D, Skudlik C, Weisshaar W, Werfel T, Worm M (2023) S2k-Leitlinie Diagnostik, Pr\u00e4vention und Therapie des Handekzems. J\u00a0Dtsch Dermatol Ges","DOI":"10.1111\/ddg.15179_g"},{"key":"5143_CR2","unstructured":"Bissonnette R (2023) FC03.04; EAACI, Mailand. https:\/\/drive.google.com\/file\/d\/1RDr_SbOG4g44SoYYP2OHusvT5SsD9Efj\/view. Zugegriffen: 20. Mrz. 2023"},{"issue":"10","key":"5143_CR3","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s00105-019-4463-z","volume":"70","author":"R Brans","year":"2019","unstructured":"Brans\u00a0R, Skudlik\u00a0C (2019) Pr\u00e4vention des Handekzems [Prevention of hand eczema]. Hautarzt 70(10):797\u2013803. https:\/\/doi.org\/10.1007\/s00105-019-4463-z","journal-title":"Hautarzt"},{"key":"5143_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/cod.12134","volume":"70","author":"TK Car\u00f8e","year":"2014","unstructured":"Car\u00f8e\u00a0TK, Ebbeh\u00f8j\u00a0N, Agner\u00a0T (2014) A survey of exposures related to recognized occupational contact dermatitis in Denmark in 2010. Contact Derm 70:56\u201362","journal-title":"Contact Derm"},{"issue":"8","key":"5143_CR5","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1080\/13543784.2022.2087059","volume":"31","author":"J Cheng","year":"2022","unstructured":"Cheng\u00a0J, Facheris\u00a0P, Ungar\u00a0B, Guttman-Yassky\u00a0E (2022) Current emerging and investigational drugs for the treatment of chronic hand eczema. Expert Opin Investig Drugs 31(8):843\u2013853. https:\/\/doi.org\/10.1080\/13543784.2022.2087059","journal-title":"Expert Opin Investig Drugs"},{"key":"5143_CR6","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1365-2133.2004.06270.x","volume":"152","author":"PJ Coenraads","year":"2005","unstructured":"Coenraads\u00a0PJ, Van Der Walle\u00a0H, Thestrup-Pedersen\u00a0K et al (2005) Construction and validation of a\u00a0photographic guide for assessing severity of chronic hand dermatitis. Br J Dermatol 152:296\u2013301","journal-title":"Br J Dermatol"},{"key":"5143_CR7","doi-asserted-by":"publisher","unstructured":"Eyerich K (2023) Molekulare Diagnostik des Handekzems. Dermatologie. https:\/\/doi.org\/10.1007\/s00105-023-05148-z","DOI":"10.1007\/s00105-023-05148-z"},{"issue":"10","key":"5143_CR8","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/exd.13077","volume":"25","author":"N Garzorz-Stark","year":"2016","unstructured":"Garzorz-Stark\u00a0N, Krause\u00a0L, Lauffer\u00a0F, Atenhan\u00a0A, Thomas\u00a0J, Stark\u00a0SP, Franz\u00a0R, Weidinger\u00a0S, Balato\u00a0A, Mueller\u00a0NS, Theis\u00a0FJ, Ring\u00a0J, Schmidt-Weber\u00a0CB, Biedermann\u00a0T, Eyerich\u00a0S, Eyerich\u00a0K (2016) A novel molecular disease classifier for psoriasis and eczema. Exp Dermatol 25(10):767\u2013774. https:\/\/doi.org\/10.1111\/exd.13077","journal-title":"Exp Dermatol"},{"key":"5143_CR9","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1111\/bjd.14019","volume":"173","author":"C Gr\u00f6nhagen","year":"2015","unstructured":"Gr\u00f6nhagen\u00a0C, Lid\u00e9n\u00a0C, Wahlgren\u00a0CF et\u00a0al (2015) Hand eczema and atopic dermatitis in adolescents: a\u00a0prospective cohort study from the BAMSE project. Br J Dermatol 173:1175\u20131182","journal-title":"Br J Dermatol"},{"key":"5143_CR10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/bjd.14476","volume":"175","author":"NG Heede","year":"2016","unstructured":"Heede\u00a0NG, Thyssen\u00a0JP, Thuesen\u00a0BH et al (2016) Predictive factors of self-reported hand eczema in adult Danes: a\u00a0population-based cohort study with 5\u2011year follow-up. Br J Dermatol 175:287\u2013295","journal-title":"Br J Dermatol"},{"key":"5143_CR11","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.1365-2133.2004.06305.x","volume":"152","author":"E Held","year":"2005","unstructured":"Held\u00a0E, Skoet\u00a0R, Johansen\u00a0JD, Agner\u00a0T (2005) The hand eczema severity index (HECSI): a\u00a0scoring system for clinical assessment of hand eczema. A study of inter- and intraobserver reliability. Br J Dermatol 152:302","journal-title":"Br J Dermatol"},{"issue":"3","key":"5143_CR12","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.jaci.2017.01.029","volume":"140","author":"A Heratizadeh","year":"2017","unstructured":"Heratizadeh\u00a0A, Werfel\u00a0T, Wollenberg\u00a0A, Abraham\u00a0S, Plank-Habibi\u00a0S, Schnopp\u00a0C, Sticherling\u00a0M, Apfelbacher\u00a0C, Biedermann\u00a0T, Breuer\u00a0K, Fell\u00a0I, F\u00f6lster-Holst\u00a0R, Heine\u00a0G, Grimm\u00a0J, Hennighausen\u00a0L, Kugler\u00a0C, Reese\u00a0I, Ring\u00a0J, Sch\u00e4kel\u00a0K, Schmitt\u00a0J, Seikowski\u00a0K, von Stebut\u00a0E, Wagner\u00a0N, Wa\u00dfmann-Otto\u00a0A, Wienke-Graul\u00a0U, Weisshaar\u00a0E, Worm\u00a0M, Gieler\u00a0U, Kupfer\u00a0J, Arbeitsgemeinschaft Neurodermitisschulung f\u00fcr Erwachsene (ARNE) Study Group (2017) Effects of structured patient education in adults with atopic dermatitis: Multicenter randomized controlled trial. J\u00a0Allergy Clin Immunol 140(3):845\u2013853.e3. https:\/\/doi.org\/10.1016\/j.jaci.2017.01.029","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"5143_CR13","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jpsychores.2009.04.014","volume":"68","author":"J Kupfer","year":"2010","unstructured":"Kupfer\u00a0J, Gieler\u00a0U, Diepgen\u00a0TL, Fartasch\u00a0M, Lob-Corzilius\u00a0T, Ring\u00a0J, Scheewe\u00a0S, Scheidt\u00a0R, Schnopp\u00a0C, Szczepanski\u00a0R, Staab\u00a0D, Werfel\u00a0T, Wittenmeier\u00a0M, Wahn\u00a0U, Schmid-Ott\u00a0G (2010) Structured education program improves the coping with atopic dermatitis in children and their parents\u2014a multicenter, randomized controlled trial. J\u00a0Psychosom Res 68(4):353\u2013358. https:\/\/doi.org\/10.1016\/j.jpsychores.2009.04.014","journal-title":"J Psychosom Res"},{"key":"5143_CR14","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/sj.jid.5700750","volume":"127","author":"A Lerbaek","year":"2007","unstructured":"Lerbaek\u00a0A, Kyvik\u00a0KO, Mortensen\u00a0J et\u00a0al (2007) Heritability of hand eczema is not explained by comorbidity with atopic dermatitis. J\u00a0Invest Dermatol 127:1632\u20131640 (Die wichtigsten Risikofaktoren sind ein manifestes atopisches Ekzem.)","journal-title":"J Invest Dermatol"},{"key":"5143_CR15","doi-asserted-by":"publisher","first-page":"437","DOI":"10.5271\/sjweh.3876","volume":"46","author":"T Lund","year":"2020","unstructured":"Lund\u00a0T, Petersen\u00a0SB, Flachs\u00a0EM et al (2020) Risk of work-related hand eczema in relation to wet work exposure. Scand J Work Environ Health 46:437\u2013445","journal-title":"Scand J Work Environ Health"},{"key":"5143_CR16","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/j.0022-202X.2005.23723.x","volume":"124","author":"B Meding","year":"2005","unstructured":"Meding\u00a0B, Wrangsj\u00f6\u00a0K, J\u00e4rvholm\u00a0B (2005) Fifteen-year follow-up of hand eczema: predictive factors. J\u00a0Invest Dermatol 124:893\u2013897","journal-title":"J Invest Dermatol"},{"key":"5143_CR17","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1055\/a-0875-4334","volume":"45","author":"G Meinel","year":"2019","unstructured":"Meinel\u00a0G, Berndt\u00a0K, Messaoudi\u00a0S, G\u00fcnther\u00a0C, Abraham\u00a0S, Bauer\u00a0A (2019) Therapierefrakt\u00e4res atopisches Ekzem \u2013 erfolgreiche Therapie mit Dupilumab. Akt Dermatol 45:219\u2013223","journal-title":"Akt Dermatol"},{"issue":"8","key":"5143_CR18","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/jamadermatol.2018.2027","volume":"154","author":"J Oosterhaven","year":"2018","unstructured":"Oosterhaven\u00a0J, Romeijn\u00a0G, Schuttelaar\u00a0M (2018) Dupilumab treatment of very severe refractory atopic hand eczema. JAMA Dermatol 154(8):969\u2013970","journal-title":"JAMA Dermatol"},{"issue":"8","key":"5143_CR19","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/1346-8138.14982","volume":"46","author":"J Oosterhaven","year":"2019","unstructured":"Oosterhaven\u00a0J, Voorberg\u00a0AN, Romeijn\u00a0G, de Bruin-Weller\u00a0MS, Schuttelaar\u00a0M (2019) Effect of dupilumab on hand eczema in patients with atopic dermatitis: An observational study. J\u00a0Dermatol 46(8):680\u2013685","journal-title":"J Dermatol"},{"key":"5143_CR20","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1111\/bjd.18295","volume":"182","author":"J Oosterhaven","year":"2020","unstructured":"Oosterhaven\u00a0J, Schuttelaar\u00a0M (2020) Responsiveness and interpretability of the hand eczema severity index. Br J Dermatol 182:932\u2013939","journal-title":"Br J Dermatol"},{"issue":"3","key":"5143_CR21","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jaad.2020.05.135","volume":"84","author":"AS Paller","year":"2021","unstructured":"Paller\u00a0AS, Stein Gold\u00a0L, Soung\u00a0J, Tallman\u00a0AM, Rubenstein\u00a0DS, Gooderham\u00a0M (2021) Efficacy and patient-reported outcomes from a\u00a0phase 2b, randomized clinical trial of tapinarof cream for the treatment of adolescents and adults with atopic dermatitis. J\u00a0Am Acad Dermatol 84(3):632\u2013638. https:\/\/doi.org\/10.1016\/j.jaad.2020.05.135","journal-title":"J Am Acad Dermatol"},{"key":"5143_CR22","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/bjd.16147","volume":"178","author":"SMD Ruff","year":"2018","unstructured":"Ruff\u00a0SMD, Engebretsen\u00a0KA, Zachariae\u00a0C et al (2018) The association between atopic dermatitis and hand eczema: a\u00a0systematic review and meta-analysis. Br J Dermatol 178:879\u2013888","journal-title":"Br J Dermatol"},{"issue":"2","key":"5143_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/cod.14015","volume":"86","author":"JBK S\u00f8lberg","year":"2022","unstructured":"S\u00f8lberg\u00a0JBK, Quaade\u00a0AS, Jacobsen\u00a0SB, Andersen\u00a0JD, Kampmann\u00a0ML, Morling\u00a0N, Litman\u00a0T, Thyssen\u00a0JP, Johansen\u00a0JD (2022) The transcriptome of hand eczema assessed by tape stripping. Contact Derm 86(2):71\u201379. https:\/\/doi.org\/10.1111\/cod.14015","journal-title":"Contact Derm"},{"key":"5143_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2022.12.024","author":"JBK S\u00f8lberg","year":"2023","unstructured":"S\u00f8lberg\u00a0JBK, Quaade\u00a0AS, Drici\u00a0L, Sulek\u00a0K, Ulrich\u00a0NH, L\u00f8vendorf\u00a0MB, Thyssen\u00a0JP, Mann\u00a0M, Dyring-Andersen\u00a0B, Johansen\u00a0JD (2023) The proteome of hand eczema assessed by tape stripping. J\u00a0Invest Dermatol. https:\/\/doi.org\/10.1016\/j.jid.2022.12.024","journal-title":"J Invest Dermatol"},{"key":"5143_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1600-0536.2009.01669.x","volume":"62","author":"JP Thyssen","year":"2010","unstructured":"Thyssen\u00a0JP, Johansen\u00a0JD, Linneberg\u00a0A, Menn\u00e9\u00a0T (2010) The epidemiology of hand eczema in the general population\u2014prevalence and main findings. Contact Dermatitis 62:75\u201387","journal-title":"Contact Dermatitis"},{"issue":"5","key":"5143_CR26","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/cod.14035","volume":"86","author":"JP Thyssen","year":"2022","unstructured":"Thyssen\u00a0JP, Schuttelaar\u00a0M, Alfonso\u00a0JH, Andersen\u00a0KE, Angelova-Fischer\u00a0I, Arents\u00a0BWM, Bauer\u00a0A, Brans\u00a0R, Cannavo\u00a0A, Christoffers\u00a0WA, Cr\u00e9py\u00a0MN, Elsner\u00a0P, Fartasch\u00a0M, Filon\u00a0FL, Gim\u00e9nez-Arnau\u00a0AM, Gon\u00e7alo\u00a0M, Guzm\u00e1n-Perera\u00a0MG, Hamann\u00a0CR, Hoetzenecker\u00a0W, Johansen\u00a0JD, John\u00a0SM, Kunkeler\u00a0ACM, Hadzavdic\u00a0SL, Molin\u00a0S, Nixon\u00a0R, Oosterhaven\u00a0J, Rustemeyer\u00a0T, Serra-Baldrich\u00a0E, Shah\u00a0M, Simon\u00a0D, Skudlik\u00a0C, Spiewak\u00a0R, Valiukevi\u010dien\u0117\u00a0S, Voorberg\u00a0AN, Weisshaar\u00a0E, Agner\u00a0T (2022) Guidelines for diagnosis, prevention, and treatment of hand eczema. Contact Derm 86(5):357\u2013378. https:\/\/doi.org\/10.1111\/cod.14035","journal-title":"Contact Derm"},{"issue":"2","key":"5143_CR27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/cod.14104","volume":"87","author":"AN Voorberg","year":"2022","unstructured":"Voorberg\u00a0AN, Romeijn\u00a0G, de Bruin-Weller\u00a0MS, Schuttelaar\u00a0M (2022) The long-term effect of dupilumab on chronic hand eczema in patients with moderate to severe atopic dermatitis\u201452 week results from the Dutch BioDay Registry. Contact Derm 87(2):185\u2013191. https:\/\/doi.org\/10.1111\/cod.14104","journal-title":"Contact Derm"},{"issue":"5","key":"5143_CR28","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.0105-1873.2006.00811.x","volume":"54","author":"E Weisshaar","year":"2006","unstructured":"Weisshaar\u00a0E, Radulescu\u00a0M, Bock\u00a0M, Albrecht\u00a0U, Diepgen\u00a0TL (2006) Educational and dermatological aspects of secondary individual prevention in healthcare workers. Contact Derm 54(5):254\u2013260","journal-title":"Contact Derm"},{"key":"5143_CR29","doi-asserted-by":"publisher","unstructured":"Wilke A et\u00a0al (2023) Patientenschulungen bei berufsbedingten Handekzemen. Dermatologie. https:\/\/doi.org\/10.1007\/s00105-023-05137-2","DOI":"10.1007\/s00105-023-05137-2"},{"issue":"5","key":"5143_CR30","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/bjd.18469","volume":"182","author":"M Worm","year":"2020","unstructured":"Worm\u00a0M, Bauer\u00a0A, Elsner\u00a0P, Mahler\u00a0V, Molin\u00a0S, Nielsen\u00a0TSS (2020) Efficacy and safety of topical delgocitinib in patients with chronic hand eczema: data from a\u00a0randomized, double-blind, vehicle-controlled phase IIa study. Br J Dermatol 182(5):1103\u20131110. https:\/\/doi.org\/10.1111\/bjd.18469","journal-title":"Br J Dermatol"},{"issue":"1","key":"5143_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/bjd.21037","volume":"187","author":"M Worm","year":"2022","unstructured":"Worm\u00a0M, Thyssen\u00a0JP, Schliemann\u00a0S, Bauer\u00a0A, Shi\u00a0VY, Ehst\u00a0B, Tillmann\u00a0S, Korn\u00a0S, Resen\u00a0K, Agner\u00a0T (2022) The pan-JAK inhibitor delgocitinib in a\u00a0cream formulation demonstrates dose response in chronic hand eczema in a\u00a016-week randomized phase IIb trial. Br J Dermatol 187(1):42\u201351. https:\/\/doi.org\/10.1111\/bjd.21037","journal-title":"Br J Dermatol"},{"key":"5143_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/cod.13828","author":"YT Y\u00fcksel","year":"2021","unstructured":"Y\u00fcksel\u00a0YT, Agner\u00a0T, Ofenloch\u00a0R (2021) New evidence on the minimal important change (MIC) for the Hand Eczema Severity Index (HECSI). Contact Derm. https:\/\/doi.org\/10.1111\/cod.13828","journal-title":"Contact Derm"},{"issue":"6","key":"5143_CR33","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/cod.14214","volume":"87","author":"YT Y\u00fcksel","year":"2022","unstructured":"Y\u00fcksel\u00a0YT, N\u00f8rreslet\u00a0LB, Olesen\u00a0CM, Agner\u00a0T (2022) Assessment of hand eczema severity: What\u2019s new? Contact Derm 87(6):556\u2013557. https:\/\/doi.org\/10.1111\/cod.14214","journal-title":"Contact Derm"},{"issue":"1","key":"5143_CR34","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jaad.2018.02.073","volume":"79","author":"MJ Zirwas","year":"2018","unstructured":"Zirwas\u00a0MJ (2018) Dupilumab for hand eczema. J\u00a0Am Acad Dermatol 79(1):167\u2013169","journal-title":"J Am Acad Dermatol"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-023-05143-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-023-05143-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-023-05143-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T22:03:45Z","timestamp":1702505025000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-023-05143-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,24]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["5143"],"URL":"https:\/\/doi.org\/10.1007\/s00105-023-05143-4","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"value":"2731-7005","type":"print"},{"value":"2731-7013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,24]]},"assertion":[{"value":"20 March 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"A.\u00a0Bauer ist oder war als Vortragende und\/oder Advisor t\u00e4tig und\/oder hat Forschungsunterst\u00fctzung erhalten von Novartis, Genentech, Leo, Sanofi, Regeneron, Shire, Takeda, Amgen, AstraZeneca, AbbVie, Celldex, Lilly, Pharvaris, Almirall, L\u2019Or\u00e9al, Incyte, Blueberry Therapeutics, Centogene, Galderma, Biofrontera und der Deutschen Gesetzlichen Unfallversicherung (DGUV). M.\u00a0Worm hat f\u00fcr Berater- und\/oder Vortragst\u00e4tigkeiten Honorare erhalten: ALK-Pharma, Almirall, Novartis Pharma GmbH, Sanofi-Aventis Deutschland GmbH, HAL Allergie GmbH, DBV Technologies S.A, Aimmune Therapeutics UK Limited, Regeneron Pharmaceuticals, Inc, Leo Pharma GmbH, Boehringer Ingelheim Pharma GmbH &Co.KG, Stallergenes GmbH, Swixx Biopharma, Pharm Research Associates (UK) Ltd, AstraZeneca GmbH, Worg Pharmaceuticals (Hangzhou) Co. Ltd., Eli Lilly, AbbVie, Genzyme.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autorinnen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}